Aduro Biotech to Present at ROTH Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Aduro Biotech (ADRO) Tops Q4 EPS by 19c
March 8, 2016 4:08 PM ESTAduro Biotech (NASDAQ: ADRO) reported Q4 EPS of $0.04, $0.19 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $34.38 million versus the consensus estimate of $15.4 million.
For earnings history and earnings-related data on Aduro Biotech (ADRO) click here.
... More